Projects per year
Fingerprint
Dive into the research topics where Neil Elliot Kay is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Outcomes for CLL patients treated with novel therapy
Kay, N. E. & Shanafelt, T. D.
9/15/21 → 8/31/24
Project: Research project
-
Predicting clinical outcome in individuals with small CLL B cell clones
Kay, N. E. & Shanafelt, T. D.
9/25/15 → 8/31/21
Project: Research project
-
Predicting Clinical Outcome After Traditional and Ibrutinib-based Therapy In Chronic Lymphocytic Leukemia
Kay, N. E. & Shanafelt, T. D.
5/19/15 → 4/30/21
Project: Research project
-
-
Chemo-Immunotherapy in Relapsed/Refactory B-Chronic Lymphocytic Leukemia
8/1/06 → 7/31/12
Project: Research project
-
Artificial Intelligence Electrocardiography to Predict Atrial Fibrillation in Patients With Chronic Lymphocytic Leukemia
Christopoulos, G., Attia, Z. I., Achenbach, S. J., Rabe, K. G., Call, T. G., Ding, W., Leis, J. F., Muchtar, E., Kenderian, S. S., Wang, Y., Hampel, P. J., Koehler, A. B., Kay, N. E., Kapoor, P., Slager, S. L., Shanafelt, T. D., Noseworthy, P. A., Friedman, P. A., Herrmann, J. & Parikh, S. A., Apr 2024, In: JACC: CardioOncology. 6, 2, p. 251-263 13 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Ibrutinib-based therapy reinvigorates CD8+ T cells compared to chemoimmunotherapy: immune monitoring from the E1912 trial
Papazoglou, D., Wang, X. V., Shanafelt, T. D., Lesnick, C. E., Ioannou, N., De Rossi, G., Herter, S., Bacac, M., Klein, C., Tallman, M. S., Kay, N. E. & Ramsay, A. G., Jan 4 2024, In: Blood. 143, 1, p. 57-63 7 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Prediction of outcomes for high-count monoclonal B lymphocytosis using an epigenetic and immunogenetic signature
Abdelbaky, S. B., Giacopelli, B., Rabe, K. G., Yamaguchi, K., Wu, Y. Z., Yan, H., Shanafelt, T. D., Parikh, S. A., Ding, W., Hampel, P. J., Brown, S., Cerhan, J. R., Vachon, C. M., Kay, N. E., Hanson, C. A., Parker, A. S., Braggio, E., Slager, S. L. & Oakes, C. C., Apr 25 2024, In: Blood. 143, 17, p. 1752-1757 6 p.Research output: Contribution to journal › Article › peer-review
Open Access -
AXL Inhibition Improves the Antitumor Activity of Chimeric Antigen Receptor T Cells
Sakemura, R. L., Hefazi, M., Cox, M. J., Siegler, E. L., Sinha, S., Hansen, M. J., Stewart, C. M., Feigin, J. M., Roman, C. M., Schick, K. J., Can, I., Tapper, E. E., Horvei, P., Adada, M. M., Bezerra, E. D., Fonkoua, L. A. K., Ruff, M. W., Forsman, C. L., Nevala, W. K., Boysen, J. C., & 11 others , Sep 1 2023, In: Cancer Immunology Research. 11, 9, p. 1237-1252 16 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Differential prognosis of single and multiple TP53 abnormalities in high-count MBL and untreated CLL
Griffin, R., Wiedmeier-Nutor, J. E., Parikh, S. A., McCabe, C. E., O’Brien, D. R., Boddicker, N. J., Kleinstern, G., Rabe, K. G., Bruins, L., Brown, S., Campos, C. B. D., Ding, W., Leis, J. F., Hampel, P. J., Call, T. G., Van Dyke, D. L., Kay, N. E., Cerhan, J. R., Yan, H., Slager, S. L., & 1 others , Jul 11 2023, In: Blood Advances. 7, 13, p. 3169-3179 11 p.Research output: Contribution to journal › Article › peer-review
Open Access